Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy

Overview of attention for article published in Oncolytic Virotherapy, April 2016

Altmetric Badge

Mentioned by

So far, Altmetric has seen 3 X posts from 1 X users, with an upper bound of 177 followers.

This work describe the potentials of Oncolytic NDV Iraqi isolate as leukemia and lymphoma therapy https://t.co/Qpjgztq7QF

Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy New Resear…https://t.co/IqidVftf1B